Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joachim Rudolph

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Angewandte Chemie (International Ed. in English)|March 5, 2014
Selective inhibition of mutant Ras protein through covalent bindingJoachim Rudolph, David Stokoe
Bioorganic & Medicinal Chemistry Letters|August 21, 2012
Ras inhibition via direct Ras binding--is there a path forward?Weiru Wang, Guowei Fang, Joachim Rudolph
Cancer Discovery|April 3, 2021
Emerging Trends in Cancer Drug Discovery-From Drugging the "Undruggable" to Overcoming ResistanceJoachim Rudolph, Jeff Settleman, Shiva Malek
Nature Reviews. Drug Discovery|July 19, 2014
Phenotypic screening in cancer drug discovery - past, present and futureJohn G Moffat, Joachim Rudolph, David Bailey
Expert Opinion on Therapeutic Patents|March 13, 2012
p21-Activated kinase inhibitors: a patent reviewJames J Crawford, Klaus P Hoeflich, Joachim Rudolph
Nature Reviews. Drug Discovery|April 28, 2026
Contemporary design of small-molecule kinase modulators: orthosteric, allosteric and induced-proximity strategiesJoachim Rudolph, Klaus P Hoeflich, Arvin C Dar
The Enzymes|July 19, 2014
p21-activated kinase inhibitorsJoachim Rudolph, James J Crawford, Klaus P Hoeflich, et al.
Journal of Medicinal Chemistry|November 22, 2014
Inhibitors of p21-activated kinases (PAKs)Joachim Rudolph, James J Crawford, Klaus P Hoeflich, et al.
Current Topics in Medicinal Chemistry|August 13, 2002
Prospects for kinase activity modulators in the treatment of diabetes and diabetic complicationsWilliam H Bullock, Steven R Magnuson, Soongyu Choi, et al.
Cancer Discovery|September 15, 2023
Which Small Molecule? Selecting Chemical Probes for Use in Cancer Research and Target ValidationMary M Mader, Joachim Rudolph, Ingo V Hartung, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Angewandte Chemie (International Ed. in English)|March 5, 2014
Selective inhibition of mutant Ras protein through covalent bindingJoachim Rudolph, David Stokoe
Bioorganic & Medicinal Chemistry Letters|August 21, 2012
Ras inhibition via direct Ras binding--is there a path forward?Weiru Wang, Guowei Fang, Joachim Rudolph
Cancer Discovery|April 3, 2021
Emerging Trends in Cancer Drug Discovery-From Drugging the "Undruggable" to Overcoming ResistanceJoachim Rudolph, Jeff Settleman, Shiva Malek
Nature Reviews. Drug Discovery|July 19, 2014
Phenotypic screening in cancer drug discovery - past, present and futureJohn G Moffat, Joachim Rudolph, David Bailey
Expert Opinion on Therapeutic Patents|March 13, 2012
p21-Activated kinase inhibitors: a patent reviewJames J Crawford, Klaus P Hoeflich, Joachim Rudolph
Nature Reviews. Drug Discovery|April 28, 2026
Contemporary design of small-molecule kinase modulators: orthosteric, allosteric and induced-proximity strategiesJoachim Rudolph, Klaus P Hoeflich, Arvin C Dar
The Enzymes|July 19, 2014
p21-activated kinase inhibitorsJoachim Rudolph, James J Crawford, Klaus P Hoeflich, et al.
Journal of Medicinal Chemistry|November 22, 2014
Inhibitors of p21-activated kinases (PAKs)Joachim Rudolph, James J Crawford, Klaus P Hoeflich, et al.
Current Topics in Medicinal Chemistry|August 13, 2002
Prospects for kinase activity modulators in the treatment of diabetes and diabetic complicationsWilliam H Bullock, Steven R Magnuson, Soongyu Choi, et al.
Cancer Discovery|September 15, 2023
Which Small Molecule? Selecting Chemical Probes for Use in Cancer Research and Target ValidationMary M Mader, Joachim Rudolph, Ingo V Hartung, et al.
Pageof 6